MedTrace Logo

Is the 4MGS a Useful Outcome Measure Post-PPCI

NCT02261324 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2021-03-12

No results posted yet for this study

Summary

This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this can predict future cardiovascular events and death.

Conditions

  • Acute Myocardial Infarction

Sponsors & Collaborators

Principal Investigators

  • William DC Man, FRCP PhD · NIHR Respiratory Biomedical Research Unit Royal Brompton & Harefield NHS Foundation Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2017-01-31
Completion
2021-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261324 on ClinicalTrials.gov